{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T20:09:02Z","timestamp":1762200542028,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370300"],"award-info":[{"award-number":["81370300"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["17JCQNJC11400"],"award-info":[{"award-number":["17JCQNJC11400"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Electrocardiology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jelectrocard.2020.04.014","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T02:25:16Z","timestamp":1587608716000},"page":"151-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Suppression of experimental atrial fibrillation in a canine model of rapid atrial pacing by the phosphodiesterase 3 inhibitor cilostazol"],"prefix":"10.1016","volume":"60","author":[{"given":"Zhiqiang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jelectrocard.2020.04.014_bb0005","first-page":"255","article-title":"The epidemiology of atrial fibrillation and stroke","volume":"34","author":"Pistoia","year":"2016","journal-title":"Cardiol Clin"},{"issue":"12","key":"10.1016\/j.jelectrocard.2020.04.014_bb0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11936-019-0793-5","article-title":"Racial differences in atrial fibrillation epidemiology, management, and outcomes","volume":"21","author":"Nanda","year":"2019","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"6S","key":"10.1016\/j.jelectrocard.2020.04.014_bb0015","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.jelectrocard.2018.09.001","article-title":"ECGI in atrial fibrillation: a clinician\u2019s wish list","volume":"51","author":"Azpilicueta","year":"2018","journal-title":"J Electrocardiol"},{"issue":"1","key":"10.1016\/j.jelectrocard.2020.04.014_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jelectrocard.2017.08.015","article-title":"Angiotensin-(1-7) prevents atrial tachycardia induced-heat shock protein 27 expression","volume":"51","author":"Wang","year":"2018","journal-title":"J Electrocardiol"},{"issue":"3","key":"10.1016\/j.jelectrocard.2020.04.014_bb0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1253\/circj.CJ-15-0138","article-title":"Role of inflammation in atrial fibrillation pathophysiology and management","volume":"79","author":"Harada","year":"2015","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.jelectrocard.2020.04.014_bb0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12872-016-0301-8","article-title":"Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing","volume":"16","author":"Yang","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"10.1016\/j.jelectrocard.2020.04.014_bb0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/MBC.0b013e32835facb3","article-title":"Mean platelet volume in patients with nonvalvular atrial fibrillation","volume":"24","author":"Tekin","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"10.1016\/j.jelectrocard.2020.04.014_bb0040","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jelectrocard.2013.11.003","article-title":"Patient-specific modeling of atrial fibrosis increases the accuracy of sinus rhythm simulations and may explain maintenance of atrial fibrillation","volume":"47","author":"Krueger","year":"2014","journal-title":"J Electrocardiol"},{"issue":"2","key":"10.1016\/j.jelectrocard.2020.04.014_bb0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2459\/JCM.0b013e3283439746","article-title":"Effects of cilostazol in the heart","volume":"12","author":"Kanlop","year":"2011","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"1","key":"10.1016\/j.jelectrocard.2020.04.014_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000338247","article-title":"Effect of cilostazol in acute lacunar infarction based on pulsatility index of transcranial Doppler (ECLIPse): a multicenter, randomized, double-blind, placebo-controlled trial","volume":"69","author":"Han","year":"2013","journal-title":"Eur Neurol"},{"issue":"3","key":"10.1016\/j.jelectrocard.2020.04.014_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/0267659113513822","article-title":"Cilostazol decreases total atrial conduction time in patients with peripheral artery disease","volume":"29","author":"Alizade","year":"2014","journal-title":"Perfusion"},{"issue":"12","key":"10.1016\/j.jelectrocard.2020.04.014_bb0060","doi-asserted-by":"crossref","first-page":"963","DOI":"10.5152\/akd.2014.5962","article-title":"Cilostazol ameliorates atrial ionic remodeling in long-term rapid atrial pacing dogs","volume":"15","author":"Zhao","year":"2015","journal-title":"Anatol J Cardiol"},{"issue":"4","key":"10.1016\/j.jelectrocard.2020.04.014_bb0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000447769","article-title":"Cilostazol prevents atrial structural remodeling through the MEK\/ERK pathway in a canine model of atrial tachycardia","volume":"135","author":"Zhao","year":"2016","journal-title":"Cardiology"},{"issue":"6","key":"10.1016\/j.jelectrocard.2020.04.014_bb0070","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/01.RES.87.6.440","article-title":"Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation","volume":"87","author":"Nattel","year":"2000","journal-title":"Circ Res"},{"issue":"24","key":"10.1016\/j.jelectrocard.2020.04.014_bb0075","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1136\/heartjnl-2018-314267","article-title":"Mechanisms of atrial fibrillation","volume":"105","author":"Wijesurendra","year":"2019","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.jelectrocard.2020.04.014_bb0080","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ijcard.2009.07.015","article-title":"Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling","volume":"146","author":"Liu","year":"2011","journal-title":"Int J Cardiol"},{"issue":"29","key":"10.1016\/j.jelectrocard.2020.04.014_bb0085","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.2174\/1381612822666160607065109","article-title":"Antiplatelet treatment in peripheral arterial disease: the role of novel antiplatelet agents","volume":"22","author":"Klonaris","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jelectrocard.2020.04.014_bb0090","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijcard.2015.04.180","volume":"190","author":"Lee","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jelectrocard.2020.04.014_bb0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.freeradbiomed.2015.07.016","article-title":"Protective effect of cilostazol against doxorubicin-induced cardiomyopathy in mice","volume":"89","author":"Koh","year":"2015","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"10.1016\/j.jelectrocard.2020.04.014_bb0100","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.hrthm.2014.05.001","article-title":"Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes","volume":"11","author":"Shinohara","year":"2014","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.jelectrocard.2020.04.014_bb0105","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.hrthm.2009.12.009","article-title":"Role of inflammation and oxidative stress in atrial fibrillation","volume":"7","author":"Li","year":"2010","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.jelectrocard.2020.04.014_bb0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/02713683.2018.1542734","article-title":"Cilostazol attenuates retinal oxidative stress and inflammation in a streptozotocin-induced diabetic animal model","volume":"44","author":"Yeh","year":"2019","journal-title":"Curr Eye Res"},{"issue":"2","key":"10.1016\/j.jelectrocard.2020.04.014_bb0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.phrs.2007.04.007","article-title":"Cilostazol reduces inflammatory burden and oxidative stress in hypertensive type 2 diabetes mellitus patients","volume":"56","author":"Agrawal","year":"2007","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.jelectrocard.2020.04.014_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/138161211795049804","article-title":"Mean platelet volume: a link between thrombosis and inflammation?","volume":"17","author":"Gasparyan","year":"2011","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.jelectrocard.2020.04.014_bb0125","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3892\/br.2015.418","article-title":"The association between mean platelet volume and chronic atrial fibrillation and the presence of thrombotic events","volume":"3","author":"Xu","year":"2015","journal-title":"Biomed Rep"},{"issue":"Suppl. 2","key":"10.1016\/j.jelectrocard.2020.04.014_bb0130","first-page":"S14","article-title":"The pharmacology of cilostazol","volume":"4","author":"Schr\u00f6r","year":"2002","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.jelectrocard.2020.04.014_bb0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cryobiol.2011.08.007","article-title":"Loading solution prevents activation damage of human platelets before lyophilization","volume":"63","author":"Zhou","year":"2011","journal-title":"Cryobiology"},{"issue":"5","key":"10.1016\/j.jelectrocard.2020.04.014_bb0140","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1592\/phco.29.5.526","article-title":"Pharmacologic therapy for intermittent claudication","volume":"29","author":"Dobesh","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.jelectrocard.2020.04.014_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jelectrocard.2006.04.001","article-title":"Effects of cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs","volume":"40","author":"Li","year":"2007","journal-title":"J Electrocardiol"},{"issue":"1","key":"10.1016\/j.jelectrocard.2020.04.014_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2007.09.026","article-title":"Structural and functional remodeling of the left atrium","volume":"51","author":"Casaclang-Verzosa","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jelectrocard.2020.04.014_bb0155","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.amjcard.2013.12.021","article-title":"Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategy","volume":"113","author":"Badheka","year":"2014","journal-title":"Am J Cardiol"},{"issue":"5A","key":"10.1016\/j.jelectrocard.2020.04.014_bb0160","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/j.1582-4934.2007.00197.x","article-title":"Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure","volume":"12","author":"Sanganalmath","year":"2008","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.jelectrocard.2020.04.014_bb0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ancard.2014.12.004","article-title":"MMP-9 in atrial remodeling in patients with atrial fibrillation","volume":"64","author":"Lewkowicz","year":"2015","journal-title":"Ann Cardiol Angeiol"},{"issue":"3","key":"10.1016\/j.jelectrocard.2020.04.014_bb0170","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/tox.22275","article-title":"Attenuation of the LPS-induced, ERK-mediated upregulation of fibrosis-related factors FGF-2, uPA, MMP-2, and MMP-9 by Carthamus tinctorius L in cardiomyoblasts","volume":"32","author":"Han","year":"2017","journal-title":"Environ Toxicol"},{"issue":"4","key":"10.1016\/j.jelectrocard.2020.04.014_bb0175","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2124","article-title":"Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation","volume":"16","author":"Rudolph","year":"2010","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.jelectrocard.2020.04.014_bb0180","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.yjmcc.2008.07.007","article-title":"Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation","volume":"45","author":"Chen","year":"2008","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.jelectrocard.2020.04.014_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12466","article-title":"Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats","volume":"36","author":"Zhang","year":"2018","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jelectrocard.2020.04.014_bb0190","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.12659\/MSM.895715","article-title":"Associations of MMP-2, BAX, and Bcl-2 mRNA and protein expressions with development of atrial fibrillation","volume":"22","author":"Diao","year":"2016","journal-title":"Med Sci Monit"},{"issue":"Suppl. 1","key":"10.1016\/j.jelectrocard.2020.04.014_bb0195","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.33549\/physiolres.933389","article-title":"Ageing related down-regulation of myocardial connexin-43 and up-regulation of MMP-2 may predict propensity to atrial fibrillation in experimental animals","volume":"65","author":"Nagibin","year":"2016","journal-title":"Physiol Res"},{"issue":"9","key":"10.1016\/j.jelectrocard.2020.04.014_bb0200","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1540-8167.2011.02059.x","article-title":"Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence","volume":"22","author":"Okumura","year":"2011","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Journal of Electrocardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073620300297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073620300297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T19:51:17Z","timestamp":1762199477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022073620300297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":40,"alternative-id":["S0022073620300297"],"URL":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2020.04.014","relation":{},"ISSN":["0022-0736"],"issn-type":[{"type":"print","value":"0022-0736"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of experimental atrial fibrillation in a canine model of rapid atrial pacing by the phosphodiesterase 3 inhibitor cilostazol","name":"articletitle","label":"Article Title"},{"value":"Journal of Electrocardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2020.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}